Ad is loading...
MEDBX vs REBAX
MEDBX vs REBAX Comparison
Open Charts MEDBX vs REBAX
MFS Emerging Markets Debt B
Price$11.97
Change+$0.04 (+0.34%)
VolumeN/A
Net Assets6.97B
Columbia Emerging Markets Bond A
Price$9.51
Change+$0.05 (+0.53%)
VolumeN/A
Net Assets277.68M
MEDBX vs REBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
MEDBX vs. REBAX commentary
May 13, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDBX is a Hold and REBAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDBX has more cash in the bank: 6.97B vs. REBAX (278M). MEDBX pays higher dividends than REBAX: MEDBX (5.77) vs REBAX (5.16). MEDBX was incepted earlier than REBAX: MEDBX (23 years) vs REBAX (19 years). MEDBX (1.82) is less costly to investors than REBAX (1.13). MEDBX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDBX has a lower initial minimum investment than REBAX: MEDBX (1000) vs REBAX (2000). REBAX annual gain was more profitable for investors over the last year : 6.48 vs. MEDBX (5.61). REBAX return over 5 years is better than : 14.72 vs. MEDBX (10.61).
| MEDBX | REBAX | MEDBX / REBAX | |
| Total Expense Ratio | 1.81 | 1.13 | 160% |
| Annual Report Gross Expense Ratio | 1.82 | 1.13 | 161% |
| Fund Existence | 23 years | 19 years | - |
| Gain YTD | 1.000 | 1.796 | 56% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 1000 | 2000 | 50% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.97B | 278M | 2,508% |
| Annual Yield % from dividends | 5.77 | 5.16 | 112% |
| Returns for 1 year | 5.61 | 6.48 | 86% |
| Returns for 3 years | 15.99 | 17.71 | 90% |
| Returns for 5 years | 10.61 | 14.72 | 72% |
| Returns for 10 years | 21.10 | 27.71 | 76% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers